The acute increased IGF1R activity in colon adenomas following exposure to EGFR blockade raises the possibility of testing tumour specimens or circulating tumour cells (de Bono et al, 2007) for their initial response to drug. This evidence concerns the gene IGF1R and colon adenoma.